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ARTICLE
Dynein regulates Kv7.4 channel trafficking from the
cell membrane
Jennifer van der Horst1, Salomé Rognant1, Geoffrey W. Abbott2, Lijo Cherian Ozhathil1, Per Hägglund1, Vincenzo Barrese3,4, Christine Y. Chuang1,
Thomas Jespersen1, Michael J. Davies1, Iain A. Greenwood3, Pontus Gourdon1,5, Christian Aalkjær1,6, and Thomas A. Jepps1
The dynein motor protein transports proteins away from the cell membrane along the microtubule network. Recently, we
found the microtubule network was important for regulating the membrane abundance of voltage-gated Kv7.4 potassium
channels in vascular smooth muscle. Here, we aimed to investigate the influence of dynein on the microtubule-dependent
internalization of the Kv7.4 channel. Patch-clamp recordings from HEK293B cells showed Kv7.4 currents were increased after
inhibiting dynein function with ciliobrevin D or by coexpressing p50/dynamitin, which specifically interferes with dynein motor
function. Mutation of a dynein-binding site in the Kv7.4 C terminus increased the Kv7.4 current and prevented p50
interference. Structured illumination microscopy, proximity ligation assays, and coimmunoprecipitation showed colocalization
of Kv7.4 and dynein in mesenteric artery myocytes. Ciliobrevin D enhanced mesenteric artery relaxation to activators of
Kv7.2–Kv7.5 channels and increased membrane abundance of Kv7.4 protein in isolated smooth muscle cells and
HEK293B cells. Ciliobrevin D failed to enhance the negligible S-1–mediated relaxations after morpholino-mediated knockdown
of Kv7.4. Mass spectrometry revealed an interaction of dynein with caveolin-1, confirmed using proximity ligation and
coimmunoprecipitation assays, which also provided evidence for interaction of caveolin-1 with Kv7.4, confirming that Kv7.4
channels are localized to caveolae in mesenteric artery myocytes. Lastly, cholesterol depletion reduced the interaction of
Kv7.4 with caveolin-1 and dynein while increasing the overall membrane expression of Kv7.4, although it attenuated the Kv7.4
current in oocytes and interfered with the action of ciliobrevin D and channel activators in arterial segments. Overall, this
study shows that dynein can traffic Kv7.4 channels in vascular smooth muscle in a mechanism dependent on cholesterol-rich
caveolae.
Introduction
The repertoire of ion channels found in the membrane of any
given cell determines the functionality of the cell. Thus, the
trafficking of ion channels into and away from the cell
membrane must be carefully controlled for the cell to main-
tain an appropriate physiological response. Ion channels
found in the cell membrane will be ultimately internalized
and either recycled back into the cell membrane or degraded.
In heterologous expression systems, the internalization and
overall surface expression of several potassium channels is
reported to be influenced by the dynein motor protein, in-
cluding the voltage-dependent Kv1.5, Kv2.1, and Kv3.1 chan-
nels (Choi et al., 2005; Loewen et al., 2009; Steele and Fedida,
2014).
Dynein is a motor protein bound to the microtubule network
that transports “cargo,” including membrane proteins, along
cellular paths created by microtubules. This motor protein
complex utilizes ATP hydrolysis to drive retrograde movement
toward the minus ends of microtubules, i.e., away from the cell
membrane (Franker and Hoogenraad, 2013; Bhabha et al., 2016).
Recently, our laboratory showed that disruption of micro-
tubules (with colchicine and nocodazole) increased the mem-
brane levels and function of the voltage-gated potassium channel
Kv7.4 (Lindman et al., 2018). In rat mesenteric and renal ar-
teries, where Kv7.4 channels are important physiologically
(Stott et al., 2014; van der Horst et al., 2020), microtubule dis-
ruption increased Kv7 channel function, which was associated
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with increased Kv7.4 membrane expression in vascular my-
ocytes. The microtubule-dependent mechanisms that orches-
trate this novel regulation pathway are yet to be determined.
The aim of this study was to investigate the influence of
dynein on the microtubule-dependent trafficking of the Kv7.4
channel. Herein, we show that dynein binds to Kv7.4 channels to
regulate their trafficking away from the cell membrane, which
has important implications in vascular physiology. Furthermore,
we identify the cholesterol-rich domains of caveolae as being
important for this process in vascular smooth muscle cells.
Materials and methods
In silico analysis
Human Kv7.1–Kv7.5, encoded by KCNQ1 to KCNQ5 genes, re-
spectively (UniProt accession nos. P51787, O43526, O43525,
P56696, and Q9NR82) and Xenopus laevis Kv7.1 (UniProt acces-
sion no. P70057), were aligned using Clustal Omega (Sievers
et al., 2011), yielding the full-sequence alignment. We identi-
fied similarity to previously identified dynein-binding motifs
(Rodŕıguez-Crespo et al., 2001). The cryo-EM structure of Xen-
opus Kv7.1 (PDB accession no. 5VMS; Sun and MacKinnon, 2017)
was visualized using PyMOL (version 1.8; Schrödinger, LLC).
Animals
All animal experiments were performed in accordance with
Directive 2010/63EU on the protection of animals used for sci-
entific purposes and were approved by the National Ethics
Committee, Denmark. Male Wistar rats were purchased from
Janvier Labs, group-housed in clear plastic containers, and un-
derwent at least 1 wk of habituation before use. All experiments
were performed using 14–17-wk-old maleWistar rats euthanized
by cervical dislocation.
Reagents
Some the main reagents used in this study are listed below.
Ciliobrevins (Tocris) are a group of small molecules that in-
hibit the motor activity of dynein by acting as ATP competitors
for the dynein adenosine triphosphatase, without disturbing
dynein binding to microtubules and without affecting other
motor proteins, such as kinesin (Firestone et al., 2012; Roossien
et al., 2015). These inhibitory effects are observed between 10
and 40 µM (Firestone et al., 2012; Eyre et al., 2014).
Methyl-β-cyclodextrin (M-βCD; Sigma-Aldrich) depletes
cholesterol (Kilsdonk et al., 1995) and disrupts caveolae in ar-
terial preparations while maintaining the contractile phenotype
at concentrations <10 mM (Dreja et al., 2002).
Filipin III (Sigma-Aldrich) is a polyene antibiotic that forms
complexes with cholesterol to reduce its ability to interact with
proteins at concentrations <10 µM, as used in this study
(Norman et al., 1972; Delgado-Ramı́rez et al., 2018).
S-1 and NS15370 (kind gift from NeuroSearch, Ballerup,
Denmark) are activators of Kv7.2–Kv7.5 channels with no effect
on Kv7.1 channels. At the concentrations used in this study, the
effects of these compounds can be fully prevented by Kv7
blockers, such as XE991 or linopirdine (Bentzen et al., 2006;
Dalby-Brown et al., 2013; Chadha et al., 2014; Jepps et al., 2014).
Plasmid construction and site-directed mutagenesis
Human KCNQ4 was subcloned into the mammalian expression
vector pEGFP-N2 (GenBank accession no: U57608), with the
gene cloned into a pEGFP-N2 vector so that it is in frame with
the enhanced GFP (EGFP) coding sequences, enabling the ex-
pression of KCNQ4 as fusion to the N terminus of EGFP. Mutant
KCNQ4 cDNA was generated by PCR-based site-directed muta-
genesis using the Quick Change II Site-Directed Mutagenesis
Kit (Agilent Technologies). Human p50 (Dynamitin/DCTN2) in
pCMV3 was purchased from Sino Biological (HG14449-UT).
Overexpression of p50 in HEK293B cells was used as a tool to
disrupt the dynein motor system by dissociating the dynactin
complex, a complex required for dynein activity (Echeverri et al.,
1996; Schroer, 2004; Loewen et al., 2009).
HEK293B cell culture and transfection
HEK293B cells were cultured to 80% confluency before passag-
ing and used for experimentation between P10 and P30. Cells
were grown in Dulbecco’s modified Eagle’s medium (DMEM)
containing, glutamax, 1% penicillin/streptomycin, and 10% FBS
(Substrate Department, the Panum Institute) in an incubator
with 5% CO2. For proximity ligation assay (PLA) experiments,
500 µl cell solution was plated on 12-mm coverslips in 24-well
plates 1 d before transfection and stored at 37°C with 5% CO2.
The cells on the coverslips were transfected at 60% confluency
with 50 ng GFP-tagged Kv7.4 or Kv7.4-Q580Amixed with 0.15 µl
Lipofectamine 2000 (Invitrogen) and 40 µl Opti-MEM (GIBCO).
The cells were incubated for 24 h at 37°C with 5% CO2. Cells were
used for PLA experiments 24 h after transfection. For Wes-
tern blotting and coimmunoprecipitation experiments,
HEK293B cells were cultured in a T25 flask and transiently
transfected with 1 µg GFP-tagged Kv7.4 or Kv7.4-Q580A mixed
with 3 µl Lipofectamine 2000 (Invitrogen) and 50 µl Opti-MEM
(GIBCO). Cells were harvested 24 h after transfection in radio-
immunoprecipitation assay buffer (in mM): 50 Tris, pH 8.0, 150
NaCl, 1% NP-40, 1% SDS, 0.5% sodium deoxycholate, and prote-
ase inhibitor cocktail (Roche) or in immunoprecipitation-lysis
buffer (in mM): 50 Tris, pH 8.5, 5 EDTA, 150 NaCl, 10 KCl, 1%
Nonidet P40, and protease inhibitor cocktail (Roche) and used
for Western blotting or coimmunoprecipitation experiments,
respectively.
Electrophysiology
HEK293B cells, cultured at 37°C in DMEM supplemented with
10% FBS and 4 mM glutamine, were transiently transfected with
1 µg EGFP-tagged Kv7.4 or Kv7.4-Q580A in a T25 flask mixed
with 3 µl Lipofectamine 2000 (Invitrogen) and 50 µl Opti-MEM
(GIBCO). Kv7.4 and Kv7.4-Q580A were coexpressed with 1 µg
p50/dynamitin (catalog: HG14449-UT; SinoBiological). The cells
were incubated for 24 h at 37°C with 5% CO2. Cells were used
24 h after transfection.
Electrophysiological recordings were performed in whole-
cell patch-clamp configuration with patch pipettes pulled from
1.5-mm borosilicate glass capillaries (World Precision Instru-
ments, Inc.) using micropipette puller P97 (Sutter Instruments
Co.). Pipette tips were polished to have a pipette resistance of
4–6 MΩ in the bath solution. The pipette solution contained (in
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mM) 110 KCl, 10 EGTA, 5.17 CaCl2, 1.42 MgCl2, 4 K2ATP, and 10
HEPES (pH 7.4 with KOH). The bath solution contained (in mM)
140 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose (pH
7.4 with NaOH). Whole-cell currents were recorded with a
Multiclamp 700B amplifier (Molecular Devices) controlled by
Clampex 10 via digidata 1550 (Molecular Devices). Data were
low-pass filtered at 5 kHz and sampled at 10 kHz. All the ex-
periments were performed at room temperature (21°C). Stock
solutions of ciliobrevin D were prepared in DMSO and diluted to
the appropriate concentration (3 µM) in the bath solutions. The
cells were incubated with ciliobrevin D for 15 min before re-
cording currents. For I-V relations, currents were recorded us-
ing a stimulation protocol consisting of voltage steps of 2 s from
holding potential of −80 mV, ranging from −60 to +40 mV.
Currents weremeasured from the end of the 2-s voltage step and
were normalized to the cell capacitance. Steady-state activation
curves were constructed by dividing the steady-state current at
each voltage to the maximum current at +40 mV. To calculate
V1/2 for each given condition, the steady-state activation
curves were fitted with a Boltzmann equation.
All analyses and preparation of the figures were done in Igor
Pro 6 (WaveMetrics Inc.).
In silico docking
The ciliobrevin D molecule was docked in silico to the human
Kv7.1 (Sun and MacKinnon, 2020) and human Kv7.4 (Li et al.,
2021) cryo-EM structures that were available at the time of
writing. Mutant channels were created by substitution in UCSF
Chimera. The unguided docking was performed with CHARMM
force fields (Grosdidier et al., 2011a) using SwissDock (Grosdidier
et al., 2011b).
Immunoprecipitation and Western blotting
For immunoprecipitation experiments using rat mesenteric ar-
tery lysate, three animals’ worth of mesenteric arteries were
pooled for protein extraction and homogenized in 200 µl lysis
buffer (in mM): 50 Tris, pH 8.5, 5 EDTA, 150 NaCl, 10 KCl, 1%
Nonidet P40, and protease inhibitor cocktail (Roche) for 10 min
at 4°C. After centrifugation at 11,000 g for 10 min at 4°C to re-
move cell debris, the supernatant was collected followed by
protein quantitation using a bicinchoninic acid Protein Assay kit
(Thermo Fisher Scientific). For immunoprecipitation of heter-
ologously expressed Kv7.4, HEK293B cells were maintained in
DMEMsupplementedwith 10% FBS and 1%penicillin-streptomycin.
Transient DNA transfections were performed with Lipofect-
amine using 1 µg Kv7.4 plasmid DNA/T25 flask. The transfected
HEK293B cells were harvested 24 h after transfection by cen-
trifugation, and then the cell pellet was incubated on ice for
30 min with 200 µl lysis buffer. After centrifugation at 11,000 g
for 10 min at 4°C, the supernatant was collected followed by
protein quantitation using a bicinchoninic acid Protein Assay
kit (Thermo Fisher Scientific).
Total cell protein lysate was immunoprecipitated using a
Dynabeads Protein G Immunoprecipitation Kit (Thermo Fisher
Scientific). Briefly, 1.5 mg magnetic dynabeads were transferred
to 1.5-ml tubes and placed on a magnet to separate the beads
from the solution. The supernatant was removed, and the beads
were resuspended with 3 µg anti-dynein antibody (ab23905;
Abcam) or anti–caveolin-1 antibody (C3237; Sigma-Aldrich) di-
luted in 200 µl antibody binding buffer. Tubes containing
Dynabeads–Ab complex were incubated with rotation for
30 min at 21°C and placed on a magnet to remove the su-
pernatant. After the Dynabeads–Ab complex was washed in Ab
binding and washing buffer, the supernatant was removed, and
the Dynabeads–Ab complex was resuspended with 1 mg total rat
mesenteric artery protein lysate or 50 µg HEK cell lysate in
200 µl PBS (pH 7.4) and incubated with rotation overnight at 4°C.
Subsequently, the Dynabeads–Ab–Ag complex was washed three
times in PBS; thereafter, the supernatant was removed, and the
Dynabeads–Ab–Ag complex was denatured at 70°C for 10 min in
the presence of 20 µl elution buffer (50 mM glycine, pH 2.8),
NuPAGE sample buffer, and reducing agent (Thermo Fisher
Scientific) to elute Ab–Ag complex from the beads. Samples of
the total supernatant were then loaded onto SDS-PAGE gels
(4–12% bis–tris; Invitrogen), subjected to electrophoresis, and
then transferred onto a polyvinylidene fluoride membrane (Im-
mobilon-FL; Sigma-Aldrich). The membrane was probed with an
anti-dynein (1:1,000; ab23905; Abcam), anti–caveolin-1 (1:2,000;
C3237; Sigma-Aldrich), anti-Kv7.4 (1:200; sc-50417; Santa Cruz
Biotechnology), or anti-GFP (1:2,000; A-11122; Thermo Fisher
Scientific) antibody. Protein bands were visualized using fluo-
rescently conjugated secondary antibodies raised in mouse and
rabbit (both at 1:10,000; Li-Cor Biosciences) and imaged and
analyzed on the Odyssey Infrared Imaging System (Li-Cor Bio-
sciences; version 5.2.5).
Mass spectrometry (MS)
Immunoprecipitated samples eluted from Dynabeads (see
above) were subjected to trypsin digestion following the filter-
aided sample preparation procedure (Wiśniewski et al., 2009).
Briefly, samples were diluted in 8 M urea and 0.1 M Tris, pH 8.5,
to 500 µl, and then concentrated on Vivaspin 500 ultrafiltration
devices (Sartorius) at 14,000 g (21°C) to a volume of <20 µl.
Following addition of 400 µl of 40 mM dithiothreitol in 8 M
urea, 0.1 M Tris, pH 8.5, samples were incubated at 21°C for
30 min and centrifuged as above. Samples were then treated
with 400 µl of 50 mM iodoacetamide in 8M urea and 0.1 M Tris,
pH 8.5, and incubated for 30 min at 21°C in the dark. The
samples were then centrifuged as above before 8 M urea and
0.1 M Tris, pH 8.0, was added (repeated twice). Finally, the
samples received 400 µl of 1.6 M urea in 0.1 M Tris, pH 8.0, and
were centrifuged to a volume of <20 µl followed by the addition
of 100 µl of 1.6 M urea in 0.1 M Tris, pH 8.0, and 1 µl sequence
grade trypsin (Promega; 0.1 µg/µl). Following overnight incu-
bation (21°C), samples were centrifuged as above, and the flow
through was subjected to solid-phase extraction on Empore C18
discs, as described previously (Rappsilber et al., 2003). Peptide
samples were analyzed on an Impact II Q-TOF mass spectrom-
eter (Bruker) coupled to a Dionex Ultimate 3000RSnano chro-
matography system (Thermo Fisher Scientific). Peptides were
loaded onto a Nanoelute C18 column (75 µm × 15 cm, 1.9-µm
particle size; Bruker) and eluted over 65 min using a gradient
elution system consisting of mobile phase A (0.1% formic acid in
H2O) and B (80% acetonitrile in H2O containing 0.1% formic
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acid) at a flow rate of 0.3 µl/min. The mass spectrometer was
operated with cycles of a MS scan followed by up to 12 tandem
MS scans of the most intense precursor ions. MaxQuant version
1.6.1.0 (www.maxquant.org) was used as a database search en-
gine for identification of peptides with the following parame-
ters: carbamidomethylation of Cys (fixed modification); Met
oxidation and N-terminal acetylation (variable modifications);
allowed number of missed cleavages, two; first search mass
tolerance, 0.07 D; and main search mass tolerance, 0.006 D. The
output data were filtered to exclude proteins that did not match
the acceptance criteria of at least two confidently matched
peptides in four out of four replicates, which were absent in
control samples from immunoprecipitations without IgG and in
the presence of normal mouse control IgG.
Immunocytochemistry
Freshly isolated rat mesenteric artery myocytes were isolated as
previously described (Jepps et al., 2015). Briefly, dissected
mesenteric arteries were placed in smooth muscle dissection
solution (SMDS) containing (in mM) 60 NaCl, 80 sodium glu-
tamate, 5 KCl, 2 MgCl2, 10 glucose, and 10 HEPES, pH 7.4, at 37°C
for 10 min. Mesenteric arteries were then placed in SMDS
containing BSA, papain, and dithiothreitol for 8 min at 37°C,
before being washed several times in ice-cold SMDS and incu-
bated again at 37°C in SMDS containing calcium, BSA, colla-
genase type F, and collagenase type H. Following several
washes in ice-cold SMDS, the tissue was triturated gently with
a glass pipette. Cells were allowed to adhere to coverslips,
then fixed in 4% paraformaldehyde in PBS at 21°C for 30 min
and incubated with a blocking solution consisting of 0.2% fish
skin gelatin in PBS containing 0.1% Triton X-100 (PBST). Cells
were then incubated with primary antibodies diluted in PBST
overnight at 4°C. Primary antibodies used were Kv7.4 (1:200;
ab65797; Abcam), dynein (1:500; ab23905; Abcam), β-tubulin
(1:500; A1126; Invitrogen) and caveolin-1 (1:500; ab17052;
Abcam), and sodium-calcium exchanger (NCX; 1:500; R3F1;
Swant). Cells were visualized with structured illumination
microscopy using a Zeiss Elyra PS.1 Super Resolution Micro-
scope (Carl Zeiss). Cells stained with the NCX antibody were
visualized using a Carl Zeiss LSM900 Confocal Super Reso-
lution Microscope with Airyscan 2. Midcell xy sections were
selected and analyzed. Total cell fluorescence and intracellular
fluorescence signals were quantified using Zen 2012 confocal
software.
In a subset of experiments, HEK293B cells transfected with
Kv7.4-EGFP (as described above) were allowed to adhere to cover-
slips, the nuclei were stained with 49,6-diamidino-2-phenylindole
(Thermo Fisher Scientific), and the cells were visualized on an
LSM780 confocal microscope (Carl Zeiss).
PLA
Colocalization of dynein with Kv7.4 or caveolin-1 and caveolin-
1 with Kv7.4 was studied with PLA in HEK293B cells stably
expressing Kv7.4 and Kv7.4-Q580A or freshly isolated rat mes-
enteric artery myocytes using the Duolink in situ (PLA) detec-
tion kit 563 (Olink) per the manufacturer’s instructions. Similar
to previous studies (Zhong et al., 2010a; Brueggemann et al.,
2014; Chadha et al., 2014; Jepps et al., 2015; Stott et al., 2016;
Barrese et al., 2020), cells were allowed to adhere to coverslips
and fixed in 4% paraformaldehyde in PBS. Cells were per-
meabilized in PBST, blocked in Duolink blocking solution, and
incubated with pairs of primary antibodies. The primary anti-
bodies employed were dynein (ab23905; Abcam), Kv7.4
(ab65797; Abcam), caveolin-1 (1:500 ab17052; Abcam), caveolin-
1 (C3237; Sigma-Aldrich), and NCX (R3F1; Swant). Combina-
tions of secondary anti-rabbit or anti-mouse antibodies of PLA
PLUS and MINUS probes were used followed by hybridization,
ligation, and amplification steps. Colocalization signals (pro-
teins located within 40 nm of each other) were visualized with
a standard Zeiss LSM710 upright laser-scanning confocal
microscope.
Myography
Third-order branches of rat mesenteric artery were removed
from the animals and cleaned of adherent tissue in physiological
salt solution (PSS) containing (in mM) 121 NaCl, 2.8 KCl, 1.6
CaCl2, 25 NaHCO3, 1.2 KH2HPO4, 1.2 MgSO4, 0.03 EDTA, and 5.5
glucose. Following dissection, vessels were cut into 2-mm seg-
ments and mounted in a wire myograph (Danish Myo Tech-
nology) for isometric tension recordings. The chambers of the
myograph contained PSS maintained at 37°C and aerated with
95% O2/5% CO2. Changes in tension were recorded continuously
by PowerLab and Chart software (ADInstruments). Arterial
segments were equilibrated for 30 min and normalized to pas-
sive force (Mulvany and Halpern, 1977). Subsequently, the ar-
teries were contracted with 10 µM of α1-adrenergic receptor
agonist methoxamine to assess viability. The chambers were
washedwith PSS before artery segments were incubated with or
without 10 µM ciliobrevin D, 5 mM M-βCD for 1 h, or 3 µM
Filipin III for 30 min. After incubation, the arteries were pre-
contracted with 10 µM methoxamine. Subsequently, Kv7.2–Kv7.5
specific activators S-1 (0.1 µM–10 µM) or NS15370 (1 nM–1 µM)
were applied to the arteries cumulatively.
Morpholino transfections
To determine the functional impact of Kv7.4 channels in
the ciliobrevin D–enhanced vasorelaxations, we employed a
morpholino-induced Kv7.4 knockdown technique that was
shown previously to efficiently knock down Kv7.4 channels in rat
mesenteric arteries (Jepps et al., 2015; Stott et al., 2018). We
transfected whole mesenteric artery segments with either a
Kv7.4-targeted morpholino or a miss-match control morpholino
(with five bases altered from the targeted sequence). Morpholino
oligonucleotides (100 nM; Gene Tools Inc.) were mixed with
Lipofectamine 2000 (Life Technologies) in Opti-MEM and left at
21°C for 2 h. The Opti-MEM mix was then added to DMEM
containing HEPES, glutamax, and NaHCO3 (Substrate Depart-
ment, the Panum Institute), and the third-order mesenteric
arteries were placed in this solution at 37°C. After 36 h of incu-
bation, arteries transfected with miss-match or Kv7.4-targeted
morpholino were mounted in the wire myograph for isometric
tension recordings, and viability was tested using 20 µM me-
thoxamine. This technique was used due to a lack of a Kv7.4-
specific inhibitors.
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Two-electrode voltage clamp (TEVC)
Complimentary RNA (cRNA) encoding human Kv7.4 was gen-
erated by in vitro transcription using the T7 polymerase
mMessage mMachine kit (Thermo Fisher Scientific) after line-
arization of a vector incorporating Xenopus β-globin 59 and 39
untranslated regions flanking the human KCNQ4 coding region
to enhance translation and cRNA stability. We quantified cRNA
by spectrophotometry. Defolliculated stage V and VI Xenopus
oocytes (Xenoocyte) were injected with Kv7.4 cRNA (10 ng total
per oocyte). Oocytes were incubated at 16°C in Barth’s saline
solution containing penicillin and streptomycin and were
washed daily for 3 d before TEVC recording. TEVC was per-
formed at room temperature using an OC-725C amplifier
(Warner Instruments) and pClamp11 software (Molecular De-
vices). For recording, oocytes were placed in a small-volume
oocyte bath (Warner Instruments) and viewed with a dissec-
tion microscope. Chemicals were sourced from Sigma Aldrich.
Bath solution was (in mM) 96 NaCl, 4 KCl, 1 MgCl2, 1 CaCl2, and
10 HEPES, pH 7.6. M-βCD was prepared fresh in bath solution
each experimental day and introduced into the oocyte recording
bath by gravity perfusion at a constant flow of 1 ml per minute
for at least 3 min before recording. Pipettes were of 1–2 MΩ
resistance when filled with 3 M KCl. We recorded currents in
response to voltage pulses to +40 mV from a holding potential of
−80 mV. Electrophysiology data analysis was performed with
Clampfit (Molecular Devices) and Origin software (OriginLab
Corporation); values are stated as mean ± SEM.
Statistical analysis
All statistical analysis was performed using GraphPad Prism 7.
Mean logEC50 (half-maximal effective concentration) and max-
imal relaxation (Rmax) values were calculated from individual
experiments and compared by an unpaired t test or, when more
than two groups were compared, a one-way ANOVA followed by
a Sidak or Tukey posttest. When it was not possible to calculate
logEC50 values, concentration-effect curves were tested with
two-way ANOVAs followed by the Bonferroni posttest with
correction for multiple comparisons. Membrane expression data
were compared with a one-way ANOVA followed by a Tukey
posttest or an unpaired t test, depending on the number of
groups in the comparison. Mean puncta in PLAs were compared
by an unpaired t test. All data are presented as means ± SEM.
Results
Dynein inhibition enhances Kv7.4 currents in HEK cells
As the dynein motor protein is critical for retrograde microtu-
bule network transport, we investigated whether a dynein-
recognition site was present in the Kv7.4 channel protein.
Similarity to two established dynein-binding motifs was iden-
tified, KSTQT and GIQVDR (Rodŕıguez-Crespo et al., 2001),
separated by a single arginine (R; Fig. 1 A). These sites are lo-
cated in the intracellular C terminus of the protein at the junc-
tion between the so-called C and D helices, distal to the
membrane. Further analysis using the structure of the homol-
ogous Kv7.1 protein (Howard et al., 2007) suggests that several
residues in the equivalent sequence-stretch of Kv7.4, specifically
the underscored residues in KSLQT-R-VDQIVG, are accessible to
the intracellular environment (Fig. 1 B). The high agreement of
these exposed amino acids with the established recognition sites,
in particular for the first motif, likely allow contact with dynein
and suggest that this interaction is based on charge comple-
mentation. We note that the motifs are rather conserved among
the Kv7 protein family, suggesting that other Kv7 channel iso-
forms may also be governed by dynein.
To test the hypothesis that these dynein-recognition sites in
Kv7.4 are crucial for the binding of dynein and regulation of the
channel, we substituted one of the intracellularly exposed amino
acids in the first motif, Q580, with alanine, which is expected to
interrupt the channel interaction with dynein. Voltage-clamp
electrophysiology experiments on HEK cells overexpressing
Kv7.4-Q580A (n = 6) showed increased Kv7.4 currents at +30 and
+40 mV compared with control Kv7.4 currents (n = 10; Fig. 1 C).
Coexpression of p50/dynamitin, to interfere with dynein func-
tion, increased Kv7.4 currents at voltages positive to 0mV (n = 5)
but had no effect on the Kv7.4-Q580A currents (n = 6; Fig. 1 C). In
addition, a dynein-specific inhibitor, 3 µM ciliobrevin D, en-
hanced the Kv7.4 currents at voltages positive to 10 mV but in-
hibited the Kv7.4-Q580A currents (n = 5–7; Fig. 1 C). The voltage
of half-maximal activation was not affected in the Q580A mu-
tant nor with cotransfection with p50 or ciliobrevin application
(Fig. 1 C).
To investigate the inhibition of the Kv7.4-Q580A current by
ciliobrevin, we performed in silico docking simulations (Fig. 1 D).
For these simulations, we used the known structure of Kv7.1 and
the recently published Kv7.4 structure (Sun and MacKinnon,
2020; Li et al., 2021). Ciliobrevin D was unable to bind to the
WTKv7.1 and Kv7.4 channels, whereas both the Kv7.1-Q560A and
Kv7.4-Q586A channels allowed ciliobrevin D to bind (Fig. 1 D). In
the simulation with Kv7.4, it appears the glutamine (Q580)
provides steric hindrance to prevent ciliobrevin D binding, but
the smaller alanine in Kv7.4-Q580A allows binding. We suggest
that binding of ciliobrevin D to this part of the C terminus would
either prevent channel multimerization or forward trafficking of
the channel from the ER (Howard et al., 2007; Haitin and Attali,
2008; Wiener et al., 2008), thereby reducing the number of
functional channels in the cell membrane, which would result in
a reduced current.
Dynein is colocalized with Kv7.4 in HEK293B cells
Western blot analysis showed that the WT Kv7.4 and Kv7.4-
Q580A channels were expressed at similar levels in HEK293B cells
(Fig. 2 A). PLA experiments showed colocalization of Kv7.4 and
dynein in HEK293B cells transfected with Kv7.4. In cells trans-
fected with Kv7.4-Q580A, the number of PLA puncta was reduced,
suggesting reduced interaction of dynein with the Kv7.4-Q580A
protein (Kv7.4-WT: 15 cells, Kv7.4-Q580A: 20 cells; P < 0.0001;
Fig. 2 B).
Dynein is expressed in vascular smooth muscle and colocalizes
with Kv7.4
The presence of dynein in rat mesenteric artery lysates was
evidenced by Western blotting (Fig. 3 A). Expression of dynein
in intact smooth muscle cells was confirmed using structured
van der Horst et al. Journal of General Physiology 5 of 19
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illumination microscopy, which showed dynein expression
throughout freshly isolated mesenteric artery smooth muscle
cells (Fig. 3 B).
Before investigating whether Kv7.4 coimmunoprecipitated
with dynein in rat mesenteric artery protein lysate, we con-
firmed that Kv7.4 is associated directly with dynein in HEK cells.
Immunoprecipitation with an anti-dynein antibody followed
by a Western blot using a GFP antibody showed an interaction
between dynein and Kv7.4 in HEK293B cells transfected with
Kv7.4 (n = 3; Fig. 3 C). Having established that this technique
allows for coimmunoprecipitation of these two proteins, we
identified Kv7.4 protein in rat mesenteric artery lysate
Figure 1. Dynein binds to the Kv7.4 C terminus. (A) Amino acid alignment of the end of the c-helix of Xenopus Kv7.1 (used for the modeling in B) and human
Kv7.1–Kv7.5 channels. (B) Close view of the Kv7 channel c-helix using the structure of Xenopus Kv7.1 suggests that several residues (highlighted in green) in the
dynein-binding motifs indeed are accessible to the intracellular environment. Those in red are not exposed to the intracellular environment and are therefore
unlikely to be required for dynein recognition. (C, i–iii) Representative whole-cell voltage clamp recordings and respective I-V relations compared between
Kv7.4 and Kv7.4-Q580A (i); when cotransfected with p50/dynamitin (ii); or incubation with 3 µM ciliobrevin D (iii). Statistical comparisons were made with a
two-way ANOVA, followed by a Bonferroni multiple comparisons test, where P < 0.05, P < 0.01, and P < 0.001 are depicted by *, **, and ***, respectively. (C iv)
Mean V1/2 for steady-state activation was compared for each condition with a one-way ANVOA. (D) Docking simulations performed with SwissDock on Kv7.1,
Kv7.4, Kv7.1-Q560A, and Kv7.4-Q580A showing ciliobrevin D binding to both mutant channels but neither WT channel. Each of the four spirals (pink, green,
orange, and gold) represent an intercellular C terminus of each of the four Kv7 protein α subunits that multimerize to form a functional channel. Mean values
are shown with error bars depicting the SEM.
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immunoprecipitated with an anti-dynein antibody (n = 3;
Fig. 3 D).
Structured illumination microscopy showed the respective
localization of dynein and Kv7.4 in freshly isolated mesenteric
artery smooth muscle cells (Fig. 3 E). Colocalization (within 40
nm) between dynein and Kv7.4 in freshly isolated mesenteric
artery smooth muscle cells was revealed by PLA (34 cells; n = 4
rats; Fig. 3 F). Taken together, these results show dynein co-
localizes with Kv7.4 in isolated rat small mesenteric artery
myocytes.
Kv7 channel function is enhanced after dynein inhibition
Enhancing Kv7 channels leads to membrane hyperpolarization,
thereby reducing the open probability of voltage-dependent
calcium channels relaxing precontracted arteries. Activators of
Kv7.2–Kv7.5 channels, such as S-1 and NS15370, elicit vaso-
relaxations, which can be fully prevented by Kv7 blockers such
as XE991 or linopirdine (Bentzen et al., 2006; Dalby-Brown et al.,
2013; Chadha et al., 2014; Jepps et al., 2014). Using these
pharmacological tools, we identified the functional role of dyn-
ein by incubating freshly isolated mesenteric artery segments
with the specific dynein inhibitor ciliobrevin D and stimulating
the precontracted arteries with increasing concentrations of the
Kv7.2–Kv7.5 activator NS15370. Incubation with 10 µM cilio-
brevin D increased the relaxation to NS15370 in vessels pre-
contractedwithmethoxamine (n = 4 or 5; EC50 P = 0.0048; Fig. 4,
A and B). We also tested an additional Kv7 channel activator, S-1,
and found that ciliobrevin D (n = 4) was able to enhance the
S-1–mediated relaxation (control n = 7; EC50 P = 0.0278; Fig. 4 C).
Incubation with ciliobrevin D had no effect on the initial con-
tractions induced by methoxamine (data not shown).
To inhibit Kv7.4 channels specifically, we knocked down
Kv7.4 protein in isolated mesenteric arteries using a targeted
morpholino to block its translation (Jepps et al., 2015). Func-
tional confirmation of Kv7.4 knockdownwas observed in vessels
transfected with the Kv7.4-targeted morpholino, where the re-
sponse to S-1 (1 µM) was inhibited compared with the miss-
match control (n = 5; P = 0.01; Fig. 4 D). S-1 relaxation was
Figure 2. The Kv7.4-Q580A mutant is less able to bind dynein. (A i) Representative Western blot with HEK293B cells transfected with WT-Kv7.4-EGFP or
Q580A-Kv7.4-EGFP showing Kv7.4-EGFP bands (∼104 kD). (A ii) Mean data comparing the Kv7.4-EGFP band intensity in the lysates from HEK293B cells
transfected with WT-Kv7.4-EGFP or Q580A-Kv7.4–EGFP. (B i) Representative images of PLAs in HEK293B cells transfected with Kv7.4 (left) or Kv7.4-Q580A
(right) using Kv7.4 and dynein antibodies. The EGFP is visualized (green) in the insets to show Kv7.4 expression. Each red punctum is representative of the Kv7
channel and dynein protein localizing within 40 nm of one another. (B ii) Quantification of puncta in HEK293B cells (Kv7.4-WT: 15 cells, Kv7.4-Q580A: 20 cells)
with Kv7.4 and dynein and the respective antibodies alone as control, according to an unpaired t test. ***, P < 0.0001. Scale bars, 5 µm. Mean values are shown
with error bars depicting the SEM.
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Figure 3. Dynein colocalizes with Kv7.4 proteins in vascular smooth muscle cells. (A) Representative Western blot showing dynein (∼74 kD) expression
in protein lysates from three different samples of rat small mesenteric artery (rMA) and in one protein lysate from untransfected HEK293B cells. (B) Rep-
resentative structured illumination microscopy images of an isolated smooth muscle cell from a rat small mesenteric artery, stained with antibodies against
β-tubulin (green) and dynein (magenta). Scale bar, 10 µm. (C) Representative Kv7.4 bands from a Western blot following coimmunoprecipitation of dynein in
HEK293B cells overexpressing Kv7.4. No bands were detected for the nonspecific binding sample (NS) or for the negative control sample (Neg ctr), where
normal mouse control IgG was used instead of the specific pulldown antibody. (D) Representative Kv7.4 bands from a Western blot with samples of rat
van der Horst et al. Journal of General Physiology 8 of 19
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enhanced significantly in miss-match control arteries by cilio-
brevin D (n = 5; Rmax 74.8 ± 7.2%; P = 0.009), whereas
morpholino-induced knockdown of Kv7.4 prevented ciliobrevin
D from enhancing S-1–mediated relaxation (Fig. 4 D). Thus,
ciliobrevin D is unable to enhance S-1 relaxation in the absence
of Kv7.4 channels.
Next, we determined whether ciliobrevin D increased the
membrane abundance of Kv7.4 channels in isolated mesenteric
myocytes. Fig. 5 A shows that incubation with 3 µM ciliobrevin
D increased the expression of Kv7.4 channels in the plasma
membrane, relative to the total cell expression (n = 9; P = 0.002).
As a control, we investigated whether the expression of the NCX
was affected by ciliobrevin D treatment. In these experiments,
ciliobrevin D had no effect of the location of the NCX in mes-
enteric artery smooth muscle cells (n = 10 or 11; Fig. 5 A). We
confirmed the ciliobrevin-induced increase of Kv7.4 membrane
expression in HEK293B cells (Fig. 5 B). In these experiments,
3 µM ciliobrevin D increased Kv7.4 membrane expression (P =
0.0026). The ciliobrevin D–induced increase in Kv7.4 membrane
expression was similar to the effect of 100 µM colchicine
treatment (n = 6 or 7; P < 0.001; Fig. 5 B), which we reported
previously (Lindman et al., 2018).
Dynein is associated with caveolae proteins
We wanted to investigate whether dynein targeted particular
vesicles in vascular smooth muscle to create a better under-
standing of how Kv7.4 is removed by dynein from the cell
membrane. Thus, we performed mass spectrometry on dynein
immunoprecipitates from rat mesenteric artery lysate. We were
unable to identify Kv7.4 as a positive hit in the dataset, with this
likely due to the low abundance of Kv7.4 protein. However, we
identified caveolin-1 as well as caveolae-associated protein
1 (cavin-1; n = 4; Table 1) as proteins interacting with dynein,
suggesting that dynein binds to proteins forming the caveolae
microdomains in the cell membrane.
To verify this interaction, we performed coimmunoprecipi-
tation assays with rat mesenteric artery lysate using antibodies
for dynein and caveolin-1. Dynein was identified in the caveolin-
1 immunoprecipitate (Fig. 6 A), and in the reverse experiment,
caveolin-1 was identified in the dynein immunoprecipitate
(Fig. 6 B). To further validate this interaction, we performed PLA
with antibodies against dynein and caveolin-1. Fig. 6 C shows PLA
puncta were detected with the dynein- and caveolin-1–specific
antibodies. Cholesterol depletion with M-βCD reduced the num-
ber of interactions between dynein and caveolin-1 (Fig. 6 C; P =
0.004).
Kv7.4 channels are found in caveolae
It is not known if Kv7.4 channels localize in cholesterol-rich
regions such as caveolae. To investigate whether Kv7.4
channels are localized to the cholesterol-rich caveolae, we
performed structured illumination microscopy on freshly iso-
lated mesenteric artery smooth muscle cells and found Kv7.4
channels to be closely localized with caveolin-1 (Fig. 7 A). To
determine colocalization between caveolin-1 and Kv7.4 chan-
nels, we performed PLA, which showed that these proteins
were localized within 40 nm in smooth muscle cells (27 cells,
n = 3 rats; Fig. 7 B). When we incubated rat mesenteric artery
myocytes with M-βCD, there was a decrease in the number of
associations between caveolin-1 and Kv7.4 (29 cells, n = 3 rats; P
= 0.008; Fig. 7 B). For a control interaction with caveolin-1, we
also tested whether the NCX protein colocalized with caveolin-
1 and if any interaction was affected by cholesterol depletion.
Similar to Kv7.4, the NCX colocalized with caveolin-1, but un-
like Kv7.4, this interaction was not affected by M-βCD treat-
ment (Fig. 7 C). Overall, these data show colocalizations
between Kv7.4 and caveolin-1 proteins, which are dependent on
cholesterol, suggesting at least some of the Kv7.4 channels
found in the cell membrane are localized in caveolae of
vascular smooth muscle cells.
Dynein trafficking of Kv7.4 is dependent on cholesterol
Dynein has been reported to cluster in cholesterol-rich micro-
domains. Therefore, we tested whether cholesterol depletion
reduced the interaction of Kv7.4 with dynein. In mesenteric
artery smooth muscle cells, PLA with antibodies against Kv7.4
and dynein showed a reduced number of interactions following
M-βCD treatment compared with control (18–20 cells, n = 3 rats;
P < 0.0001; Fig. 8 A). Structured illumination microscopy
showed that Kv7.4 membrane expression was increased fol-
lowing M-βCD treatment (n = 8–10 cells; P = 0.0001; Fig. 8 B),
which was similar to the increase observed with ciliobrevin D
treatment. As a control, we observed that the membrane ex-
pression of the NCX was unaffected by M-βCD treatment
(Fig. 8 B).
Cholesterol depletion inhibits Kv7 channel function in
mesenteric arteries
To determine the effect of cholesterol depletion on Kv7.4 cur-
rents, we performed TEVC experiments on oocytes over-
expressing Kv7.4. Application of 1 mM M-βCD inhibited the
Kv7.4 current at 40 mV in four out of five oocytes (P = 0.0029;
Fig. 9 A). Incubation of rat mesenteric arteries with M-βCD
inhibited NS15370 relaxation (n = 8–14; EC50 P < 0.0001; Fig. 9,
B and C). Saturation of M-βCD with cholesterol restored the
vasodilation to NS15370 (n = 5; Fig. 9, B and C). Interestingly,
ciliobrevin D was unable to enhance the NS15370 relaxation in
the presence of M-βCD (n = 6; Fig. 9, B and C). To confirm the
effect of cholesterol depletion on Kv7 channel function in arteries,
we also tested Filipin III. Similar to M-βCD, Filipin III inhibited
mesenteric artery protein lysate (rMA) that were immunoprecipitated (IP) with a dynein antibody. Each rMA sample contains n = 3 rats’ worth of mesenteric
arteries. (E) Representative structured illumination microscopy image of an isolated smooth muscle cell from a rat small mesenteric artery stained with
antibodies against Kv7.4 (magenta) and dynein (green). Scale bar, 10 µm. (F i) Representative image of PLAs with Kv7.4 and dynein antibodies in mesenteric
artery myocytes. Each red punctum is representative of the Kv7 channel and dynein protein localizing within 40 nm of one another. (F ii) Quantification of
puncta in 34 cells (n = 4 rats) with Kv7.4 and dynein and the respective antibodies alone as control. Mean values are shown with error bars depicting the SEM.
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NS15370 relaxation in rat mesenteric artery segments (n = 7; EC50
P = 0.0078; Fig. 9 D). Taken together, these experiments suggest
that arterial Kv7 channels require cholesterol to maintain their
normal function.
Discussion
Our laboratory showed previously that microtubule disruption
enhanced Kv7 channel–dependent vasorelaxation, which was
mediated by an increase in Kv7.4 channel levels in the membrane
Figure 4. Kv7 channel function is enhanced
following dynein inhibition. (A) Representative
isometric tension recordings of rat mesenteric
artery segments preconstricted with methoxa-
mine (•) before sequentially increasing concen-
trations of Kv7.2–Kv7.5–specific activator NS15370
were applied in control (left) and ciliobrevin D–
treated (right) arteries. (B)Mean concentration-effect
curves and EC50 values to the Kv7.2–Kv7.5–specific
activator NS15370 showing the effect of NS15370
in rat mesenteric artery segments before and after
10 µM ciliobrevin D incubation. Mean EC50 values
were compared according to an unpaired t test. **,
P < 0.01. (C) 10 µM ciliobrevin D enhanced the
relaxation to another Kv7.2–Kv7.5 channel activa-
tor, S-1, according to an unpaired t test. *, P < 0.05.
(D) Rat mesenteric arteries were transfected with
either a Kv7.4-targeted or the control (miss-match)
morpholino. Relaxations to S-1 were inhibited in
arteries transfected with the Kv7.4-targeted mor-
pholino compared with arteries transfected with
the control morpholino. Ciliobrevin D enhanced
relaxations to S-1 in control arteries, but ciliobrevin
D was unable to enhance S-1–mediated relaxation
in Kv7.4 knockdown arteries. A one-way ANOVA
followed by a Sidak multiple comparisons test was
performed, with ** and *** denoting P < 0.01 and
P < 0.001, respectively. Error bars show the mean
and SEM.
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(Lindman et al., 2018). In the current study, we investigated the
mechanisms behind this microtubule-dependent regulation of
Kv7.4 channels. Our data not only provide the first evidence of
dynein influencing Kv7.4 channel trafficking but also show that
this dynein-dependent process regulates vascular function and
depends on cholesterol-rich caveolae.
In heterologous expression systems, dynein influences the
expression of several potassium channels (Choi et al., 2005;
Loewen et al., 2009); but none had investigated the Kv7 channel
family. Given our previous findings (Lindman et al., 2018), we
focused on the Kv7.4 channel, and similar to previous studies
investigating the role of dynein on Kv channels, we adopted an
Figure 5. Dynein inhibition increases membrane expression of Kv7.4 protein. (A, i–iii) Representative midcell z-section of a mesenteric artery myocyte
treated with or without ciliobrevin D and stained for Kv7.4 (top) or NCX (bottom; i). Scale bars, 10 μm. Mean membrane intensity of Kv7.4 (n = 9; ii) and NCX
(n = 10 or 11; iii) relative to total intensity in cells treated with ciliobrevin D compared with nontreated cells, calculated frommidcell z section. Significance was
determined by an unpaired t test. **, P < 0.001. (B i) Representative midcell z section of HEK293B cells transfected with Kv7.4-EGFP (green) in nontreated and
ciliobrevin D– or colchicine-treated cells. The nuclei are stained with 49,6-diamidino-2-phenylindole (blue). Scale bars, 10 μm. (B ii)Mean membrane intensity
of Kv7.4 relative to total intensity in cells treated with ciliobrevin D (n = 5) or colchicine (n = 7) compared with nontreated cells (n = 6), calculated frommidcell z
section. Significance was determined by a one-way ANOVA. **, P < 0.001; ***, P < 0.0001. Error bars show mean and SEM.
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electrophysiological approach. Both overexpression of p50/
dynamitin, to interfere with dynein function, and ciliobrevin D,
to inhibit the movement of dynein, increased the Kv7.4 current
in HEK293B cells. In silico analysis of the Kv7.4 channel iden-
tified two dynein recognition sites in the C terminus of the
channel. Mutating an exposed glutamine residue (580) con-
firmed dynein’s ability to bind to this region, since the currents
produced by this channel were larger than the Kv7.4 WT cur-
rents, increasing to a similar degree as ciliobrevin D treatment
on the WT channel, and neither p50 overexpression nor cilio-
brevin D treatment was able to increase the mutant Kv7.4
current density. Overexpression of p50 had a greater effect on
the Kv7.4 current than ciliobrevin D treatment and the Kv7.4-
Q580A mutation did. Coexpression of p50 is known to disrupt
many dynein-dynactin–dependent processes. The exact mech-
anism of disruption is not completely clear but probably in-
volves disruption of the dynein–dynactin interaction (Schroer,
2004). This disruption to the dynein–dynactin complex is
known to alter dynein-dependent retrograde, as well as an-
terograde, transport of membrane proteins and multiple or-
ganelles by disrupting the binding of the dynein complex to its
cargo (Burkhardt et al., 1997; Utrilla et al., 2017). Overall, such
treatment can completely rearrange the organelles in the cells,
including the Golgi, ER, and lysosomes (Burkhardt et al., 1997).
With such a multitude of effects on cell function, it is not
Table 1. Proteins identified following dynein immunoprecipitation,
trypsin digestion, and liquid chromatography–tandem MS analysis
Protein UniProt accession no.
Caveolae-associated protein 1 G3V8L9
Caveolin-1 Q2IBC6
Cytoplasmic dynein 1 heavy chain 1 F1LRT9
Cytoplasmic dynein 1 intermediate chain 2 D3ZU74
The identifications were based on at least two peptides matched confidently
per protein in four of four replicates, which were absent in control samples
from immunoprecipitations without IgG and in the presence of normal
mouse control IgG.
Figure 6. Dynein colocalizes with caveolin-1 proteins. (A) Representative dynein (∼74 kD) bands from a Western blot with rat mesenteric artery protein
lysate (rMA) that was immunoprecipitated (IP) with a caveolin-1 (Cav-1) antibody (n = 3) and the total protein lysate as positive control. (B) Representative
caveolin-1 (∼22 kD) bands from a Western blot with rMA that was immunoprecipitated with a dynein antibody (n = 3) and the total protein lysate as positive
control. Each rMA sample contains n = 3 rats’worth of mesenteric arteries. No bands for dynein or Cav-1 were detected for the nonspecific binding sample (NS)
or for the negative control sample (Neg ctr) where normal rabbit/mouse control IgG was used instead of the specific pulldown antibody. (C i) Representative
images of PLA in smooth muscle cells from rat mesenteric arteries with dynein and caveolin-1 antibodies in control (left) and M-βCD–treated (right) cells. Red
puncta indicate that target proteins are in close proximity (<40 nM). Scale bars, 10 μm. (C ii) Quantification of the number of PLA puncta in mesenteric artery
myocytes (34 cells, n = 4 rats) showing significant decrease of dynein and caveolin-1 colocalization in M-βCD treated cells (**, P = 0.004 according to an
unpaired t test). Error bars represent SEM.
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Figure 7. Kv7.4 channels colocalize with caveolin-1. (A) Representative midcell z section of an isolated smooth muscle cell from a rat small mesenteric
artery stained with antibodies against caveolin-1 (Cav-1; magenta) and Kv7.4 (green). Scale bar, 10 µm. Insets show the brightfield images of the cells.
(B i) Representative images of PLAs in smooth muscle cells from rat mesenteric arteries with Kv7.4 and caveolin-1 antibodies in control (left) and
M-βCD–treated (right) cells. Red puncta indicate target proteins are in close proximity (<40 nM). (B ii) Quantification of the number of PLA puncta in
mesenteric artery myocytes (control: 27 cells, n = 3 rats; M-βCD: 29 cells, n = 3 rats) showing significant decrease of Kv7.4 and caveolin-1 colocalization in
M-βCD–treated cells (**, P = 0.008 according to an unpaired t test). (C i) Representative images of PLAs in smooth muscle cells from rat mesenteric arteries
with NCX and caveolin-1 antibodies in control (left) and M-βCD–treated (right) cells. Red puncta indicate target proteins are in close proximity (<40 nM). (C ii) Quan-
tification of the number of PLA puncta in mesenteric artery myocytes (control, 10 cells; M-βCD, 10 cells) showing equal colocalization of NCX and caveolin-1 in
M-βCD–treated cells compared with nontreated cells. Error bars represent SEM.
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possible, within the scope of this study, to determine why p50
overexpression had an enhanced effect on the WT Kv7.4 current
compared with ciliobrevin D treatment and the Kv7.4-Q580A
mutation. Nevertheless, these data highlight the importance of the
dynein recognition sequence in the C terminus of Kv7.4 channels
for dynein-dependent regulation since the Kv7.4-Q580A mutant
was completely unaffected by p50 overexpression. Given that this
glutamine residue is conserved throughout the Kv7 channel
family, this dynein-dependent transport mechanism may be a
common mechanism in several organs where these channels are
also important physiologically, such as the heart, brain, pancreas,
and smooth muscle cells.
One striking effect from our electrophysiological studies was
the inhibition of the Kv7.4-Q580A currents by ciliobrevin D. To
investigate this effect, we performed in silico docking experi-
ments with the known structures for Kv7.1 and Kv7.4. These
data showed that ciliobrevin D could bind to the mutant channel,
but not theWT Kv7.1 or Kv7.4 channels, in an area important for
channel multimerization and trafficking from the ER (Howard
et al., 2007; Haitin and Attali, 2008; Wiener et al., 2008). We
propose, therefore, that the binding of ciliobrevin D to the mu-
tant channel prevents the functional formation of Kv7.4 chan-
nels in the cell membrane, thereby inhibiting the current. Given
this off-target effect of ciliobrevin D on the mutant Kv7.4
channel, it is not possible to interpret the effect of ciliobrevin
D on the dynein-dependent regulation of the Kv7.4-Q580A
channel.
It is well established that vascular voltage-gated Kv7 potas-
sium channels are important regulators of arterial tone, with
activation of the Kv7 channels hyperpolarizing the membrane,
leading to a relaxation of the smooth muscle cells and concom-
itant vasodilatation (Zhong et al., 2010b; Ng et al., 2011; Jepps
et al., 2014; Stott et al., 2014). Kv7.4 and Kv7.5 are the two pre-
dominant functional isoforms in vascular smooth muscle cells,
where they mostly form heteromeric Kv7.4/7.5 channels
(Brueggemann et al., 2014; Chadha et al., 2014; Jepps et al.,
Figure 8. Dynein trafficking of Kv7.4 is de-
pendent on cholesterol. (A i) Representative
images of PLAs in smooth muscle cells from rat
mesenteric arteries with Kv7.4 and dynein anti-
bodies in control (left) and M-βCD–treated
(right) cells. Red puncta indicate target proteins
are in close proximity (<40 nM). Scale bars, 10
μm. (A ii) Quantification of the number of PLA
puncta in mesenteric artery myocytes (control,
20 cells, n = 2 rats; M-βCD, 18 cells, n = 2 rats)
showing significant decrease of Kv7.4 and
caveolin-1 colocalization in M-βCD–treated cells
(***, P < 0.0001 according to an unpaired t test).
(B i) Representative midcell z section of a mes-
enteric artery myocyte treated with or without
M-βCD and stained for caveolin-1 (Cav-1; ma-
genta) and Kv7.4 or NCX (green). (B ii) Mean
membrane intensity of Kv7.4 relative to total
intensity in cells increased with M-βCD (n = 10)
compared with nontreated control cells (n = 8;
according to a one-way ANOVA. ***, P < 0.0001).
Scale bars, 5 μm. (B iii) Mean membrane inten-
sity of NCX relative to total intensity in cells was
equal in M-βCD–treated cells (n = 10) and non-
treated control cells (n = 9–11). The intensity of
caveolin-1 was the same for both groups. Error
bars show mean values and SEM.
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Figure 9. Cholesterol depletion inhibits Kv7 channel function in mesenteric arteries. (A i) Representative recording of a Kv7.4 current from a Xenopus
oocyte before (black) and after (red) application of 1 mM M-βCD. (A ii) Mean data showing the effect of M-βCD on the Kv7.4 current in Xenopus oocytes at
40 mV (n = 5). **, P < 0.01 according to a paired t test. (B) Representative isometric tension recordings of rat mesenteric artery segments preconstricted with
methoxamine (•) before sequentially increasing concentrations of Kv7.2–Kv7.5–specific activator NS15370 were applied in (from left to right) control,
M-βCD–treated, cholesterol-saturated M-βCD–treated, and M-βCD + ciliobrevin D–treated arteries. (C)Mean concentration-effect curves and EC50 values for
the Kv7.2–Kv7.5–specific activator NS15370 in isometric tension recordings from either segments of mesenteric artery treated with 5 mMM-βCD (blue, n = 8),
van der Horst et al. Journal of General Physiology 15 of 19
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2015). Therefore, we investigated whether the Kv7.4–dynein
interaction observed in HEK293B cells was physiologically
relevant in vascular smooth muscle.
Using PLA and coimmunoprecipitation assays, we identified
dynein colocalization with Kv7.4 in isolated vascular smooth
muscle cells and mesenteric artery lysate. Following this, we
found that the relaxations to two different Kv7.2–Kv7.5 activa-
tors, S-1 and NS15370 (Jepps et al., 2014), were enhanced by
dynein inhibition, suggesting an increase in Kv7 channel func-
tion. To test this interpretation, we knocked down Kv7.4 protein
in mesenteric artery segments (Jepps et al., 2015). Since the
targeted morpholino produced a knockdown of Kv7.4 by in-
serting a splice site, thereby rendering the expressed protein
nonfunctional, we assessed successful knockdown using the
functional myography responses. As such, there was no relax-
ation to S-1 following incubation with the Kv7.4-targeted mor-
pholino. Dynein inhibition enhanced the S-1 response in control
morpholino-transfected arteries but had no effect in arteries
where Kv7.4 was knocked down. We confirmed that Kv7.4
protein was increased in the membrane of both mesenteric ar-
tery smooth muscle cells and HEK293B cells following cilio-
brevin D treatment and used the expression of the NCX as a
negative control for these experiments. These results confirm
that dynein is involved in the removal of the channels from the
cell membrane of vascular smooth muscle cells and that inhi-
bition of dynein increases the number of Kv7.4 channels in the
membrane, thereby increasing the functional impact of the
channel in the arteries.
Since their discovery, ciliobrevin compounds have been used
by several groups to investigate the functional roles of dynein
(Eyre et al., 2014; Fu et al., 2014; Sikirzhytski et al., 2014; Cao
et al., 2015); however, this is the first study to exploit these in-
hibitors to reveal a cardiovascular role for dynein. Although the
use of such inhibitors can be complicated by off-target effects,
our electrophysiological data show that ciliobrevin D can in-
crease Kv7.4 channel currents, and our Kv7.4 morpholino data
provide compelling evidence that the enhanced S-1 effects with
ciliobrevin D arise from increased Kv7.4 channel function.
Although we identified a direct binding site for dynein on
Kv7.4, blocking dynein function does not prevent endocytosis
and recycling of early endosomes (Granger et al., 2014; Rezaul
et al., 2016). Therefore, we speculated that the Kv7.4 protein was
internalized in a vesicle that was targeted by dynein for removal
away from the cell membrane, perhaps through binding to the
Kv7.4 channel directly. We performed mass spectrometry on
mesenteric artery protein lysates to investigate dynein-bound
proteins that could comprise a functional vesicle in which the
Kv7.4 protein was being trafficked. Strikingly, caveolae proteins
were identified in the mass spectrometry experiments. We
confirmed the interaction of dynein with caveolin-1 by coim-
munoprecipitation and PLA.
Caveolae are cholesterol-rich regions of the smooth muscle
cell plasma membrane formed by membrane proteins called
caveolins and cavins, in particular caveolin-1, which is essential
for caveolae formation (Root et al., 2015; Parton et al., 2018).
These flask-shaped plasma membrane microdomains (50–100
nm) are enriched in lipids such as cholesterol and sphingolipids,
where cholesterol is the major component and is crucial for the
structural integrity of the microdomain. Several membrane
proteins localize in caveolae (Dart, 2010; Villar et al., 2016), and
Kv7.1–Kv7.3 channels are known to localize in cholesterol-rich
domains (Oldfield et al., 2009; Roura-Ferrer et al., 2010; Zhang
et al., 2013; Oliveras et al., 2014; Delgado-Ramı́rez et al., 2018).
Although caveolae provide important microdomains in the cell
membrane, they are also internalized as motile vesicles impor-
tant for the transport of certain proteins within or across po-
larized cells (Mundy et al., 2002). Several studies have shown
that intracellular caveolae movement is regulated by micro-
tubules, with disruption of the microtubule network increasing
membrane expression of caveolae (Mundy et al., 2002; Tagawa
et al., 2005; Head et al., 2006, 2014). Importantly, dyneinmotors
cluster around cholesterol-rich microdomains in various cells
types, which is thought to be an important regulatory mecha-
nism for this motor, allowing it to function efficiently (Johansson
et al., 2005; Rocha et al., 2009; Rai et al., 2016; Wijdeven et al.,
2016).
Our data show that dynein and Kv7.4 proteins can interact
with the caveolin-1 protein of caveolae. Depleting cholesterol in
the cells reduced the number of interactions between Kv7.4 and
dynein, as well as dynein interactions with caveolin-1. This de-
pletion increased membrane localization of Kv7.4 proteins to a
similar extent as ciliobrevin D treatment. In line with previous
studies showing that dynein clusters to cholesterol-rich micro-
domains (Johansson et al., 2005; Rocha et al., 2009; Rai et al.,
2016; Wijdeven et al., 2016), our data show that cholesterol is an
integral component of this dynein-dependent trafficking mecha-
nism. Thus, when Kv7.4 proteins are located in the cholesterol-
rich caveolae, they can be targeted by dynein for retrograde
trafficking from the membrane.
Since Kv7.4 membrane expression was enhanced after cho-
lesterol depletion, we speculated that M-βCD would enhance
Kv7.4 channel currents and Kv7-specific arterial relaxations to a
similar extent as ciliobrevin D treatment did. Surprisingly,
M-βCD inhibited currents arising from oocyte overexpression
of Kv7.4, and in myography experiments, the relaxation to
NS15370 was attenuated after cholesterol depletion withM-βCD.
This effect was confirmed using the cholesterol-binding agent
Filipin III. In addition, ciliobrevin D incubation had no effect on
5 mM M-βCD supplemented with cholesterol (green, n = 5), 10 µM ciliobrevin D (red, n = 10), or 5 mM M-βCD + 10 µM ciliobrevin D (orange, n = 6) or from
control vessels (black, n = 14) when methoxamine was used to preconstrict the artery segments. M-βCD significantly attenuates the relaxation for NS15370,
while cholesterol-saturated M-βCD had no effect compared with control vessels. Ciliobrevin D was unable to enhance relaxation in M-βCD–treated vessels.
(D) Mean concentration-effect curves and EC50 values for the Kv7.2–Kv7.5–specific activator NS15370 in isometric tension recordings from segments of
mesenteric artery treated with 3 µM Filipin III. 3 µM Filipin III significantly attenuates relaxation for NS15370. Statistical comparisons on the mean EC50 values
were performed with a one-way ANOVA followed by a Tukey multiple comparisons test. *, P < 0.05; **, P < 0.001; ***, P < 0.0001. Error bars show mean
values and SEM.
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the M-βCD–induced inhibition of NS15370 relaxation, suggest-
ing that the inhibition was not related to cell tracking or the
number of channel proteins in the plasma membrane and
functionally confirming the need for cholesterol to target
dynein-dependent trafficking of Kv7.4 channels. Previously,
Kv7.2/7.3 channel activity was inhibited after cholesterol de-
pletion (Delgado-Ramı́rez et al., 2018), and we suggest that
vascular Kv7 channels require cholesterol and/or caveolae not
only to be trafficked but also for correct function within the cell
membrane. M-βCD has been used in several studies investigat-
ing smooth muscle function, where it has affected multiple ion
channels and proteins (Löhn et al., 2000; Dreja et al., 2002;
Smith et al., 2005; Morikage et al., 2006; Shmygol et al., 2007;
Sones et al., 2010), which may also account for the reduced Kv7
channel function in our arterial preparations.
As the focus of this study was on understanding Kv7.4 traf-
ficking, we have not characterized the implications of the
dynein–caveolin-1 interaction further. In addition, the precise
molecular interactions regulating dynein binding to the
caveolae–Kv7.4 complex have not been investigated. For exam-
ple, oxysterol-binding protein-related protein 1L (ORP1L) is a
cholesterol-sensing switch essential for dynein tethering and the
minus-end transport of certain vesicles (Johansson et al., 2005;
Wijdeven et al., 2016; Rout et al., 2018). Investigating these
proteins and their associations with dynein and Kv7.4 in smooth
muscle cells may provide further insights into this trafficking
mechanism. Finally, we have shown that despite increased
membrane expression, cholesterol depletion inhibits the Kv7-
dependent relaxation of arteries. One limitation of our study is
the lack of whole-cell Kv7 currents from mesenteric artery
smooth muscle cells; however, the direct inhibitory effect of
M-βCD on Kv7.4 currents in oocytes, taken together with pre-
vious findings that Kv7.2/3 channels are inhibited by M-βCD
(Delgado-Ramı́rez et al., 2018), is good evidence that Kv7.4
channels require cholesterol to function normally. Additional
experiments are required to fully elucidate the role of cholesterol
and the caveolae on Kv7.4 channel function.
The importance of caveolae in orchestrating signaling path-
ways is highlighted by their role in hypertension, where a re-
duction in the number of caveolae is a hallmark feature of
arteries from hypertensive animals (Li et al., 2005; Albinsson
et al., 2007; Rahman and Swärd, 2009; Swärd et al., 2013; Lian
et al., 2019). Additionally, Kv7.4 channels are down-regulated
and attenuated functionally in arteries from hypertensive ani-
mals (Jepps et al., 2011; Chadha et al., 2012). The results of this
study indicate that future experiments should determine if the
Kv7.4 down-regulation in arteries from hypertensive animals is
associated with a reduced number of caveolae, with this possibly
driven by a dysregulated microtubule network.
In summary, this study set out to determine if the
microtubule-dependent regulation of Kv7.4 channels was
through the dynein motor protein. We identified a dynein-
binding domain in the C terminus of the Kv7.4 protein, which
allows dynein to regulate Kv7.4 channel membrane expression.
This interaction is relevant physiologically in vascular smooth
muscle, where it is likely to underlie the microtubule-dependent
regulation of Kv7.4 described previously (Lindman et al., 2018).
Furthermore, we have shown that dynein binds to caveolae
proteins, where Kv7.4 channels appear to reside. Overall, this
study provides the first evidence for a physiological role for
dynein in vascular smooth muscles and outlines a complex reg-
ulatory trafficking mechanism for the Kv7.4 channel. Further
work is required to fully understand the details of this associa-
tion, as well as the potential role of other proteins regulated by
dynein in smooth muscle cells.
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Abbott, C. Aalkjær, and T.A. Jepps all acquired and analyzed
data. L.C. Ozhathil, T. Jespersen, P. Gourdon, G.W. Abbott, P.
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